Works matching IS 14642662 AND DT 2010 AND VI 11

Results: 115

Nevirapine-associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya.

Published in:

2010

By:

Peters P;
Stringer J;
McConnell M;
Kiarie J;
Ratanasuwan W;
Intalapaporn P;
Potter D;
Mutsotso W;
Zulu I;
Borkowf C;
Bolu O;
Brooks J;
Weidle P

Publication type:

Journal Article

Defining high HIV incidence subgroups of Australian homosexual men: implications for conducting HIV prevention trials in low HIV prevalence settings.

Published in:

2010

By:

Poynten I;
Jin F;
Prestage G;
Kaldor J;
Kippax S;
Grulich A

Publication type:

Journal Article

'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients.

Published in:

2010

By:

Bourgeois N;
Bastien P;
Reynes J;
Makinson A;
Rouanet I;
Lachaud L

Publication type:

Journal Article

Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients.

Published in:

2010

By:

Lambert-Niclot S;
Machouf N;
Peytavin G;
Soulie C;
Wirden M;
Simon A;
Murphy R;
Katlama C;
Thomas R;
Calvez V;
Marcelin A

Publication type:

Journal Article

HIV and pulmonary arterial hypertension: a systematic review.

Published in:

2010

By:

Janda S;
Quon B;
Swiston J

Publication type:

Journal Article

A screening algorithm for HIV-associated neurocognitive disorders.

Published in:

2010

By:

Cysique L;
Murray J;
Dunbar M;
Jeyakumar V;
Brew B

Publication type:

Journal Article

British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals.

Published in:

2010

By:

Gilleece Y;
Chadwick D;
Breuer J;
Hawkins D;
Smit E;
McCrae L;
Pillay D;
Smith N;
Anderson J

Publication type:

Journal Article

Defining high HIV incidence subgroups of Australian homosexual men: implications for conducting HIV prevention trials in low HIV prevalence settings IM Poynten et al. Identifying populations for prevention trials.

Published in:

HIV Medicine, 2010, v. 11, n. 10, p. 635, doi. 10.1111/j.1468-1293.2010.00833.x

By:

Poynten, I. M.;
Jin, F.;
Prestage, G. P.;
Kaldor, J. M.;
Kippax, S.;
Grulich, A. E.

Publication type:

Article

Screening for 'window-period' acute HIV infection among pregnant women in rural South Africa.

Published in:

2010

By:

Kharsany A;
Hancock N;
Frohlich J;
Humphries H;
Abdool Karim S;
Abdool Karim Q

Publication type:

Journal Article

Nevirapine-associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya PJ Peters et al. Nevirapine-associated hepatotoxicity.

Published in:

HIV Medicine, 2010, v. 11, n. 10, p. 650, doi. 10.1111/j.1468-1293.2010.00873.x

By:

Peters, P. J.;
Stringer, J.;
McConnell, M. S.;
Kiarie, J.;
Ratanasuwan, W.;
Intalapaporn, P.;
Potter, D.;
Mutsotso, W.;
Zulu, I.;
Borkowf, C. B.;
Bolu, O.;
Brooks, J. T.;
Weidle, P. J.

Publication type:

Article

A note of thanks to referees for Volume 11, 2010.

Published in:: HIV Medicine, 2010, v. 11, n. 10, p. 674, doi. 10.1111/j.1468-1293.2010.00894.x
Publication type:: Article

HIV and pulmonary arterial hypertension: a systematic review S Janda et al. HIV and pulmonary arterial hypertension.

Published in:

HIV Medicine, 2010, v. 11, n. 10, p. 620, doi. 10.1111/j.1468-1293.2010.00829.x

By:

Janda, S.;
Quon, B. S.;
Swiston, J.

Publication type:

Article

'Active chronic visceral leishmaniasis' in HIV-1-infected patients demonstrated by biological and clinical long-term follow-up of 10 patients N Bourgeois et al. Active chronic visceral leishmaniasis.

Published in:

HIV Medicine, 2010, v. 11, n. 10, p. 670, doi. 10.1111/j.1468-1293.2010.00846.x

By:

Bourgeois, N.;
Bastien, P.;
Reynes, J.;
Makinson, A.;
Rouanet, I.;
Lachaud, L.

Publication type:

Article

Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients S Lambert-Niclot et al. Atazanavir inhibitory quotient in first-line therapy

Published in:

HIV Medicine, 2010, v. 11, n. 10, p. 666, doi. 10.1111/j.1468-1293.2010.00839.x

By:

Lambert-Niclot, S.;
Machouf, N.;
Peytavin, G.;
Soulie, C.;
Wirden, M.;
Simon, A.;
Murphy, R. L.;
Katlama, C.;
Thomas, R.;
Calvez, V.;
Marcelin, A.-G.

Publication type:

Article

A screening algorithm for HIV-associated neurocognitive disorders Cysique et al. NeuroAIDS algorithm.

Published in:

HIV Medicine, 2010, v. 11, n. 10, p. 642, doi. 10.1111/j.1468-1293.2010.00834.x

By:

Cysique, L. A.;
Murray, J. M.;
Dunbar, M.;
Jeyakumar, V.;
Brew, B. J.

Publication type:

Article

Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites.

Published in:

HIV Medicine, 2010, v. 11, n. 9, p. 554, doi. 10.1111/j.1468-1293.2010.00824.x

By:

Belloso, W. H.;
Orellana, L. C.;
Grinsztejn, B.;
Madero, J. S.;
La Rosa, A.;
Veloso, V. G.;
Sanchez, J.;
Ismerio Moreira, R.;
Crabtree-Ramirez, B.;
Garcia Messina, O.;
Lasala, M. B.;
Peinado, J.;
Losso, M. H.

Publication type:

Article

British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals 2010 Y Gilleece et al. British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals 2010.

Published in:

HIV Medicine, 2010, v. 11, n. 10, p. 611, doi. 10.1111/j.1468-1293.2010.00889.x

By:

Gilleece, Y.;
Chadwick, D. R.;
Breuer, J.;
Hawkins, D.;
Smit, E.;
McCrae, L. X.;
Pillay, D.;
Smith, N.;
Anderson, J.

Publication type:

Article

HIV and the body: a review of multidisciplinary management.

Published in:

HIV Medicine, 2010, v. 11, p. 1, doi. 10.1111/j.1468-1293.2010.00859.x

By:

Rockstroh, J;
Guaraldi, G;
Deray, G

Publication type:

Article

Predictors of growth and body composition in HIV-infected children beginning or changing antiretroviral therapy.

Published in:

HIV Medicine, 2010, v. 11, n. 9, p. 573, doi. 10.1111/j.1468-1293.2010.00823.x

By:

Chantry, C. J.;
Cervia, J. S.;
Hughes, M. D.;
Alvero, C.;
Hodge, J.;
Borum, P.;
Moye, Jr., J.

Publication type:

Article

Interleukin-6 and D-dimer levels are associated with vascular dysfunction in patients with untreated HIV infection.

Published in:

2010

By:

Baker J;
Quick H;
Hullsiek KH;
Tracy R;
Duprez D;
Henry K;
Neaton JD

Publication type:

Journal Article

Screening for 'window-period' acute HIV infection among pregnant women in rural South Africa ABM Kharsany et al. Screening for acute HIV infection in pregnancy.

Published in:

HIV Medicine, 2010, v. 11, n. 10, p. 661, doi. 10.1111/j.1468-1293.2010.00838.x

By:

Kharsany, A. B. M.;
Hancock, N.;
Frohlich, J. A.;
Humphries, H. R.;
Karim, S. S. Abdool;
Karim, Q. Abdool

Publication type:

Article

Nonoccupational HIV post-exposure prophylaxis: a 10-year retrospective analysis.

Published in:

HIV Medicine, 2010, v. 11, n. 9, p. 584, doi. 10.1111/j.1468-1293.2010.00826.x

By:

Tissot, F.;
Erard, V.;
Dang, T.;
Cavassini, M.

Publication type:

Article

Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions.

Published in:

HIV Medicine, 2010, v. 11, n. 9, p. 545, doi. 10.1111/j.1468-1293.2010.00827.x

By:

Rubio, R;
Serrano, O;
Carmena, J;
Asensi, V;
Echevarría, S;
Flores, J;
Ribera, E;
Zarraga, M;
Ocampo, A;
de la Fuente, B;
Sepúlveda, MA;
Mariño, AI;
Minguez, C;
Vicent, R;
Cartón, JA;
Moyano, B;
Esteban, H;
Mahillo, B;
Serrano, L;
González-García, J

Publication type:

Article

HIV-1 drug resistance mutations in children after failure of first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

Published in:

HIV Medicine, 2010, v. 11, n. 9, p. 565, doi. 10.1111/j.1468-1293.2010.00828.x

By:

Puthanakit, T.;
Jourdain, G.;
Hongsiriwon, S.;
Suntarattiwong, P.;
Chokephaibulkit, K.;
Sirisanthana, V.;
Kosalaraksa, P.;
Petdachai, W.;
Hansudewechakul, R.;
Siangphoe, U.;
Suwanlerk, T.;
Ananworanich, J.

Publication type:

Article

Efavirenz directly modulates the oestrogen receptor and induces breast cancer cell growth.

Published in:

HIV Medicine, 2010, v. 11, n. 9, p. 603, doi. 10.1111/j.1468-1293.2010.00831.x

By:

Sikora, M. J.;
Rae, J. M.;
Johnson, M. D.;
Desta, Z.

Publication type:

Article

Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decades.

Published in:

HIV Medicine, 2010, v. 11, n. 9, p. 593, doi. 10.1111/j.1468-1293.2010.00832.x

By:

Lai, A.;
Riva, C.;
Marconi, A.;
Balestrieri, M.;
Razzolini, F.;
Meini, G.;
Vicenti, I.;
Rosi, A.;
Saladini, F.;
Caramma, I.;
Franzetti, M.;
Rossini, V.;
Galli, A.;
Galli, M.;
Violin, M.;
Zazzi, M.;
Balotta, C.

Publication type:

Article

Interleukin-6 andd-dimer levels are associated with vascular dysfunction in patients with untreated HIV infection.

Published in:

2010

By:

Baker, J.;
Quick, H.;
Hullsiek, K. H.;
Tracy, R.;
Duprez, D.;
Henry, K.;
Neaton, J. D.

Publication type:

Letter

Prevalence of mutations and determinants of genotypic resistance to etravirine (TMC125) in a large Italian resistance database (ARCA)

Published in:

2010

By:

Di Vincenzo P;
Rusconi S;
Adorni F;
Vitiello P;
Maggiolo F;
Francisci D;
Di Biagio A;
Monno L;
Antinori A;
Boeri E;
Punzi G;
Perno C;
Callegaro A;
Bruzzone B;
Zazzi M;
Antiretroviral Resistance Cohort Analysis (ARCA) Collaborative Group

Publication type:

Journal Article

Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD).

Published in:

2010

By:

Oyomopito R;
Lee MP;
Phanuphak P;
Lim PL;
Ditangco R;
Zhou J;
Sirisanthana T;
Chen YMA;
Pujari S;
Kumarasamy N;
Sungkanuparph S;
Lee CKC;
Kamarulzaman A;
Oka S;
Zhang FJ;
Mean CV;
Merati T;
Tau G;
Smith J;
Li PCK

Publication type:

Journal Article

Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy.

Published in:

2010

By:

Lattuada E;
Vallone A;
Lanzafame M;
Corsini F;
Concia E;
Vento S

Publication type:

Journal Article

HIV-1 proviral resistance mutations: usefulness in clinical practice.

Published in:

HIV Medicine, 2010, v. 11, n. 8, p. 483, doi. 10.1111/j.1468-1293.2009.00814.x

By:

Kabamba-Mukadi, B.;
Duquenne, A.;
Henrivaux, P.;
Musuamba, F.;
Ruelle, J.;
Yombi, J.-C.;
Bodéus, M.;
Vandercam, B.;
Goubau, P.

Publication type:

Article

No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial.

Published in:

HIV Medicine, 2010, v. 11, n. 8, p. 493, doi. 10.1111/j.1468-1293.2009.00817.x

By:

Calmy, A.;
Bloch, M.;
Wand, H.;
Delhumeau, C.;
Finlayson, R.;
Rafferty, M.;
Norris, R.;
Hirschel, B.;
Cooper, D. A.;
Carr, A.

Publication type:

Article

Sexually transmitted infections and infectiousness beliefs among people living with HIV/AIDS: implications for HIV treatment as prevention.

Published in:

HIV Medicine, 2010, v. 11, n. 8, p. 502, doi. 10.1111/j.1468-1293.2009.00818.x

By:

Kalichman, S. C.;
Eaton, L.;
Cherry, C.

Publication type:

Article

Prevalence of mutations and determinants of genotypic resistance to etravirine (TMC125) in a large Italian resistance database (ARCA).

Published in:

HIV Medicine, 2010, v. 11, n. 8, p. 530, doi. 10.1111/j.1468-1293.2009.00819.x

By:

Di Vincenzo, P.;
Rusconi, S.;
Adorni, F.;
Vitiello, P.;
Maggiolo, F.;
Francisci, D.;
Di Biagio, A.;
Monno, L.;
Antinori, A.;
Boeri, E.;
Punzi, G.;
Perno, C.-F.;
Callegaro, A.;
Bruzzone, B.;
Zazzi, M.

Publication type:

Article

HIV-associated obliterative portopathy (HIV-OP) underlies cryptogenic liver disease in HIV-seropositive patients.

Published in:

2010

By:

Mallet, V. O.;
Sultanik, P. S.;
Vallet-Pichard, A.;
Pol, S.

Publication type:

Letter

Prior Mycobacterium avium complex infection is linked to immunological nonresponsiveness in HIV-infected patients on highly active antiretroviral therapy.

Published in:

2010

By:

Lattuada, E.;
Vallone, A.;
Lanzafame, M.;
Corsini, F.;
Concia, E.;
Vento, S.

Publication type:

Letter

Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD).

Published in:

HIV Medicine, 2010, v. 11, n. 8, p. 519, doi. 10.1111/j.1468-1293.2010.00822.x

By:

Oyomopito, R.;
Lee, M. P.;
Phanuphak, P.;
Lim, P. L.;
Ditangco, R.;
Zhou, J.;
Sirisanthana, T.;
Chen, Y. M. A.;
Pujari, S.;
Kumarasamy, N.;
Sungkanuparph, S.;
Lee, C. K. C.;
Kamarulzaman, A.;
Oka, S.;
Zhang, F. J.;
Mean, C. V.;
Merati, T.;
Tau, G.;
Smith, J.;
Li, P. C. K.

Publication type:

Article

Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.

Published in:

HIV Medicine, 2010, v. 11, n. 8, p. 510, doi. 10.1111/j.1468-1293.2010.00825.x

By:

Hosseinipour, M. C.;
Kumwenda, J. J.;
Weigel, R.;
Brown, L. B.;
Mzinganjira, D.;
Mhango, B.;
Eron, J. J.;
Phiri, S.;
van Oosterhout, J. J.

Publication type:

Article

Effects of highly active antiretroviral therapy on vaccine-induced humoral immunity in HIV-infected adults.

Published in:

HIV Medicine, 2010, v. 11, n. 8, p. 535, doi. 10.1111/j.1468-1293.2010.00830.x

By:

González, R.;
Castro, P.;
García, F.;
Plana, M.;
Bayas, J. M.;
Lafuente, S.;
Serrano, B.;
Mora, B.;
Argelich, R.;
Gatell, J. M.;
Vilella, A.

Publication type:

Article

Prevention of mother-to-child transmission of HIV in Denmark, 1994-2008.

Published in:

2010

By:

von Linstow ML;
Rosenfeldt V;
Lebech AM;
Storgaard M;
Hornstrup T;
Katzenstein TL;
Pedersen G;
Herlin T;
Valerius NH;
Weis N

Publication type:

Journal Article

Microalbuminuria predicts overt proteinuria among patients with HIV infection.

Published in:

HIV Medicine, 2010, v. 11, n. 7, p. 419, doi. 10.1111/j.1468-1293.2009.00805.x

By:

Szczech, L. A.;
Menezes, P.;
Quinlivan, E. Byrd;
van der Horst, C;
Bartlett, J. A.;
Svetkey, L. P.

Publication type:

Article

Definitions of antiretroviral treatment failure for measuring quality outcomes.

Published in:

HIV Medicine, 2010, v. 11, n. 7, p. 427, doi. 10.1111/j.1468-1293.2009.00808.x

By:

Samaranayake, A.;
Chen, M. Y.;
McNeil, J.;
Read, T. R. H.;
Hocking, J. S.;
Bradshaw, C. S.;
Fairley, C. K.

Publication type:

Article

Trends over calendar time in antiretroviral treatment success and failure in HIV clinic populations.

Published in:

HIV Medicine, 2010, v. 11, n. 7, p. 432, doi. 10.1111/j.1468-1293.2009.00809.x

By:

Bansi, L.;
Sabin, C.;
Delpech, V.;
Hill, T.;
Fisher, M.;
Walsh, J.;
Chadborn, T.;
Easterbrook, P.;
Gilson, R.;
Johnson, M.;
Porter, K.;
Anderson, J.;
Gompels, M.;
Leen, C.;
Ainsworth, J.;
Orkin, C.;
Nelson, M.;
Rice, B.;
Phillips, A.

Publication type:

Article

HIV and people over 50 years old in Europe.

Published in:

HIV Medicine, 2010, v. 11, n. 7, p. 479, doi. 10.1111/j.1468-1293.2009.00810.x

By:

Lazarus, J. V.;
Nielsen, K. K.

Publication type:

Article

Serum lipid profile in highly active antiretroviral therapy-naïve HIV-infected patients in Cameroon: a case-control study.

Published in:

2010

By:

Nguemaïm N;
Mbuagbaw J;
Nkoa T;
Alemnji G;
Této G;
Fanhi T;
Asonganyi T;
Samé-Ekobo A

Publication type:

Journal Article

Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practice.

Published in:

HIV Medicine, 2010, v. 11, n. 7, p. 439, doi. 10.1111/j.1468-1293.2009.00812.x

By:

Macías, J.;
González, J.;
Ortega, E.;
Tural, C.;
Cabrero, E.;
Burgos, A.;
Pineda, J. A.

Publication type:

Article

Risk of high-level viraemia in HIV-infected patients on successful antiretroviral treatment for more than 6 months.

Published in:

HIV Medicine, 2010, v. 11, n. 7, p. 457, doi. 10.1111/j.1468-1293.2009.00813.x

By:

Engsig, F. N.;
Omland, L. H.;
Larsen, M. V.;
Rasmussen, L. D.;
Qvist, T.;
Gerstoft, J.;
Obel, N.

Publication type:

Article

Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients.

Published in:

HIV Medicine, 2010, v. 11, n. 7, p. 462, doi. 10.1111/j.1468-1293.2009.00815.x

By:

Bedimo, R.;
Westfall, A. O.;
Mugavero, M.;
Drechsler, H.;
Khanna, N.;
Saag, M.

Publication type:

Article

History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change.

Published in:

HIV Medicine, 2010, v. 11, n. 7, p. 469, doi. 10.1111/j.1468-1293.2009.00816.x

By:

Reekie, J.;
Mocroft, A.;
Ledergerber, B.;
Beniowski, M.;
Clotet, B.;
van Lunzen, J.;
Chiesi, A.;
Pradier, C.;
Machala, L.;
Lundgren, J. D.

Publication type:

Article

Prevention of mother-to-child transmission of HIV in Denmark, 1994–2008.

Published in:

HIV Medicine, 2010, v. 11, n. 7, p. 448, doi. 10.1111/j.1468-1293.2009.00811.x

By:

von Linstow, M. L.;
Rosenfeldt, V.;
Lebech, A. M.;
Storgaard, M.;
Hornstrup, T.;
Katzenstein, T. L.;
Pedersen, G.;
Herlin, T.;
Valerius, N. H.;
Weis, N.

Publication type:

Article